István Peták

2.2k total citations
61 papers, 1.8k citations indexed

About

István Peták is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, István Peták has authored 61 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 33 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in István Peták's work include Cell death mechanisms and regulation (17 papers), Lung Cancer Treatments and Mutations (14 papers) and Cancer-related Molecular Pathways (11 papers). István Peták is often cited by papers focused on Cell death mechanisms and regulation (17 papers), Lung Cancer Treatments and Mutations (14 papers) and Cancer-related Molecular Pathways (11 papers). István Peták collaborates with scholars based in Hungary, United States and United Kingdom. István Peták's co-authors include Janet A. Houghton, David M. Tillman, Rudolf Mihalik, László Kopper, Gábor Barna, Leslie Douglas, Richárd Schwab, Gÿorgý Kéri, Gergely Imre and Franklin G. Harwood and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

István Peták

60 papers receiving 1.8k citations

Peers

Countries citing papers authored by István Peták

Since Specialization

Citations

This map shows the geographic impact of István Peták's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by István Peták with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites István Peták more than expected).

Fields of papers citing papers by István Peták

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by István Peták. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by István Peták. The network helps show where István Peták may publish in the future.

Co-authorship network of co-authors of István Peták

This figure shows the co-authorship network connecting the top 25 collaborators of István Peták. A scholar is included among the top collaborators of István Peták based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with István Peták. István Peták is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors 2023 ·World Journal of Pediatrics ·(unknown), (unknown), (unknown), (unknown), (unknown), Róbert Dóczi, (unknown), (unknown), (unknown), (unknown), (unknown), István Szegedi, (unknown), (unknown), Réka Simon, Péter Hauser, (unknown), Csongor Kiss, Miklós Garami, István Peták	1
2	Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support 2021 ·Diagnostics ·(unknown), Róbert Dóczi, (unknown), Ákos Boldizsár, Ágnes Varga, (unknown), (unknown), (unknown), (unknown), Richard B. Schwab, (unknown), (unknown), István Vályi‐Nagy, (unknown), Zsuzsanna Nagy, István Peták	0
3	Combination of multifunctional ursolic acid with kinase inhibitors for anti-cancer drug carrier vesicles 2021 ·Materials Science and Engineering C ·András Lörincz, Judith Mihály, András Wacha, Cs. Németh, (unknown), (unknown), Zoltán Varga, István Peták, Attila Bóta	8
4	Major Clinical Response to Afatinib Monotherapy in Lung Adenocarcinoma Harboring EGFR Exon 20 Insertion Mutation 2020 ·Clinical Lung Cancer ·László Urbán, Róbert Dóczi, (unknown), (unknown), M. Horváth, (unknown), (unknown), Zsolt Pápai-Székely, (unknown), (unknown), Richard B. Schwab, Csilla Hegedüs, István Vályi‐Nagy, István Peták	8
5	The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies 2019 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Veronika Zámbó, Ede Birtalan, Tibor Krenács, David L. Becker, Miklós Csala, István Vályi‐Nagy, István Peták, (unknown)	8
6	p16INK4 expression is of prognostic and predictive value in oropharyngeal cancers independent of human papillomavirus status: a Hungarian study 2016 ·European Archives of Oto-Rhino-Laryngology ·(unknown), Ede Birtalan, (unknown), (unknown), Tibor Krenács, József Tı́már, (unknown), (unknown), (unknown), László Tamás, István Peták	9
7	Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma 2016 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), (unknown), (unknown), (unknown), Ede Birtalan, Nóra Meggyesházi, Tibor Krenács, László Tamás, István Peták	15
8	Staurosporine Induces Necroptotic Cell Death under Caspase-Compromised Conditions in U937 Cells 2012 ·PLoS ONE ·Zsuzsanna A. Dunai, Gergely Imre, Gábor Barna, Tamás Korcsmáros, István Peták, Pál I. Bauer, Rudolf Mihalik	85
9	Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas 2011 ·Oral Oncology ·Balázs Szabó, (unknown), (unknown), István Kenessey, (unknown), (unknown), István Peták, Gábor Lotz, (unknown), Balázs Hegedűs, Tibor Füle, Balázs Döme, József Tı́már, József Tóvári	74
10	Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy 2010 ·Cancer Research ·Giulia Grisendi, Rita Bussolari, (unknown), István Peták, Valeria Rasini, Elena Veronesi, Giorgio De Santis, Carlotta Spano, (unknown), (unknown), (unknown), Franco Bambi, Antonio Frassoldati, Giulio Rossi, Christian Casali, Uliano Morandi, Edwin M. Horwitz, Paolo Paolucci, Pierfranco Conté, Massimo Dominici	198
11	ROR1 expression is not a unique marker of CLL 2010 ·Hematological Oncology ·Gábor Barna, Rudolf Mihalik, Botond Tímár, (unknown), Zsolt Csende, Anna Sebestyén, Csaba Bödör, Balázs Csernus, (unknown), István Peták, András Matolcsy	62
12	Functional Evaluation of Multidrug Resistance Transporter Activity in Surgical Samples of Solid Tumors 2007 ·Assay and Drug Development Technologies ·Richárd Schwab, Tamás Micsík, (unknown), Eszter Schäfer, (unknown), Tibor Tihanyi, Péter Kupcsulik, (unknown), (unknown), I Besznyák, Attila Zaránd, Rudolf Mihalik, Balázs Sarkadi, Gÿorgý Kéri, Ákos Pap, F Jakab, László Kopper, István Peták	5
13	Comparison of Elisa-Based Tyrosine Kinase Assays for Screening EGFR Inhibitors 2005 ·Journal of Receptors and Signal Transduction ·(unknown), Eszter Schäfer, (unknown), (unknown), László Őrfi, István Peták, Ákos Pap, (unknown), Gÿorgý Kéri, Richárd Schwab	19
14	Interferon-gamma pharmacokinetics and pharmacodynamics in patients with colorectal cancer 2004 ·Cancer Chemotherapy and Pharmacology ·Janet A. Houghton, István Peták, David M. Tillman, Leslie Douglas, Lee S. Schwartzberg, (unknown), John C. Panetta, (unknown), P. Kellie Turner	20
15	In vitro and in vivo antitumor effect of 2‐methoxyestradiol on human melanoma 2004 ·International Journal of Cancer ·Judit Dobos, József Tı́már, József Bocsi, (unknown), (unknown), Gábor Barna, István Peták, Andrea Ladányi	47
16	A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells 2003 ·Cell Death and Differentiation ·István Peták, (unknown), (unknown), (unknown), Kamel Izeradjene, Leslie Douglas, David M. Tillman, Darren C. Phillips, Janet A. Houghton	28
17	Molecular pathology of tumor metastasis III 2003 ·Pathology & Oncology Research ·József Tı́már, Andrea Ladányi, István Peták, András Jeney, László Kopper	9
18	Regulation of FasL by NF-κB and AP-1 in Fas-dependent Thymineless Death of Human Colon Carcinoma Cells 2000 ·Journal of Biological Chemistry ·Franklin G. Harwood, Shailaja Kasibhatla, István Peták, (unknown), Douglas R. Green, Janet A. Houghton	68
19	A Specifically Radiolabeled Somatostatin Analog with Strong Antitumor Activity Induces Apoptosis and Accumulates in the Cytosol and the Nucleus of HT29 Human Colon Carcinoma Cells 1999 ·Endocrine ·(unknown), (unknown), Béla Szende, (unknown), Anikó Horváth, Éva Hunyadi‐Gulyás, Géza Tóth, István Peták, József Bocsi, (unknown)	9
20	Apoptotic Cell Death Induced by Inhibitors of Energy Conservation 1997 ·European Journal of Biochemistry ·Attila Marton, Rudolf Mihalik, András Bratincsák, Vilmos Adleff, István Peták, (unknown), Pál I. Bauer, Péter Krajcsi	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact